...
| Country | Date | Response |
|---|---|---|
| USA | 27OCT2020 | The proposal seems generally reasonable. A few value sets in NLM's Value Set Authority Center refer to Allergy to animal x dander (finding) concepts and will be directly affected if we do inactivation/creation rather than modification (which I can understand for editorial reasons). I am wondering whether procedure concepts also referring to "animal x dander" remain appropriate or would need to be refactored similarly to the corresponding Allergy concepts – they could be similarly genericized (e.g., Cat allergen specific immunoglobulin E antibody measurement). Just a thought. |
| NL | 27OCT2020 | Agreed! |
| IRL | 27/10/2020 | OK here, as these terms at not currently in use here. |
| AUS |
| Just checking the evaluation procedures/observables will remain as these seem to be pretty standard across the industry.
There are also tests for urine, serum, epithelium individually and combinations of Otherwise, I think the change is reasonable for Clinical Findings. It's consistent to how 232350006|House dust mite allergy| is modelled. Presumably, this doesn't just apply to dander but all the 'animal materials', ie. feathers. Will this pattern also be extended to plants? pollens/seed Could just use even general substances like 'dog material substance' (Subtsance from dog) |
| DK |
| Are the FSN and PT in the example correct? In the example if the PT is | Allergy to horse | the FSN would be | Allergy to horse protein |, but can you talk about at ‘horse protein’? This sounds especially strange if this statement in the Summary is true: “In addition, the same allergenic protein may be found in several different sources”. I suppose this means that the same allergenic protein can be found in e.g. a zebra and so it would not be a ‘horse protein’ only. I am thinking that maybe the FSN should have been | Allergy to Animal protein x |, but this would not match the PT | Allergy to horse | either. I am not an allergist, but a terminologist, so perhaps I just do not understand this subject. Perhaps an example with an actual case would be helpful? /Camilla |
| CA | November 16, 2020 | Unfortunately we did not have any Canadian stakeholders commenting on this question. I agree with Camilla's second paragraph there and was not sure how to replicate a simple example that would make sense for the FSN: Allergy to cat dander (finding) would become: Allergy to cat protein (finding). |
| Member countries without a CMAG rep |
...